All updated as on -
Treatment of Kidney Stones The market size was predicted to reach 4.15 billion USD by 2031, up from 2.23 billion USD in 2023. The expected expansion of the renal stones management business throughout the projected timeframe is driven by the increasing prevalence and recurrence rate of kidney stones. Kidney stones are caused by a variety of factors, including poor nutrition, lack of water, obesity, and an excessive intake of salt.
The development of stones in the kidneys, bladder, or urinary system is known as urolithiasis, and it is the most prevalent urological illness. Causes of kidney stones in the aforementioned regions include reduced urine output and an increase in the excretion of oxalate, calcium, cysteine, urate, phosphate, and xanthine, among other substances. Modern medicine has developed excellent procedures and devices for treating kidney stones.
The American Urologic Association reports that the expense of diagnosing and treating kidney stones, both directly and indirectly, has been rising in recent years. Healthcare spending for kidney stone disease management has gone up, even if there have been improvements in therapeutic and surgical treatment methods. Medical treatment for kidney stones in the United States is projected to cost 1.24 billion dollars per year by 2031, according to the National Center for Biotechnology Information (NCBI). Patients have been able to keep their healthcare costs down because to technology advancements that have allowed for shorter hospital stays and less invasive surgical treatments.
Revenue in the kidney stone management market was negatively affected by the COVID-19 outbreak. There has been an effect on the implementation of kidney stone management methods from the increasing demand for COVID-19 treatment. People avoided various medical procedures in healthcare facilities due to the pandemic, which raised the incidence and death rates from coronavirus. All elective surgical treatments, whether performed in an outpatient or inpatient setting, were outlawed in numerous countries once they proclaimed a national emergency. These factors had an effect on the expansion of the worldwide market for kidney stones management.
Optimal therapy and better management of stones of any size have been made possible by technological developments and the introduction of novel products. In 2014, the GLIDEWAY ureteral access sheath was introduced by Terumo Corporation. It is utilized in minimally invasive urologic operations. The LithoVue single-use digital flexible ureteroscopes, introduced to the European market by Boston Scientific in 2016, offered superior visualization compared to the market leaders in 2016.
The kidney stone management devices market is anticipated to be influenced by ongoing research into the prevention and effective treatment of kidney stone illnesses. For example, a two-year clinical trial to find out how to avoid kidney stone recurrence was initiated in 2017 by Duke Clinical Research Institute (DCRI), a scientific data research center for the Urinary Stone Disease Research Network. The American Urological Association (AUA) also issued updated recommendations for the surgical removal of kidney stones in 2016. Most importantly, patients and doctors should work together to decide on a course of treatment and therapy for kidney stones. Renal stones, which are small, hard mineral deposits inside the kidneys, as well as ureteral stones, are addressed in these advice from experts.
Report Coverage
Global Kidney Stone Management Devices research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Kidney Stone Management Devices report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Kidney Stone Management Devices competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Kidney Stone Management Devices market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Kidney Stone Management Devices market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Kidney Stone Management Devices market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Allengers Medical Systems Ltd, Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, Coloplast A/S, Karl Storz GmbH, Richard Wolf GmbH, Dornier MedTech, EDAP TMS S.A, Medispec Ltd, DirexGroup, Elmed Medical Systems, Becton, Dickinson and Company, Siemens Healthineers.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Kidney Stone Management Devices market based on the below-mentioned segments:
Global Kidney Stone Management Devices Market, By Type
Calcium oxalate
Calcium phosphate
Uric acid
Struvite
Cysteine
Global Kidney Stone Management Devices market, By Diagnostics
Abdominal X-ray
Computed tomography
Ultrasound
Abdominal MRI
Intravenous pyelography
Others
Global Kidney Stone Management Devices Market, By Treatment
Extracorporeal shock wave lithotripsy (ESWL)
Ureteroscopy
Percutaneous nephrolithotomy (PCNL)
Others
Global Kidney Stone Management Devices market, Regional Analysis
The development of stones in the kidneys, bladder, or urinary system is known as urolithiasis, and it is the most prevalent urological illness. Causes of kidney stones in the aforementioned regions include reduced urine output and an increase in the excretion of oxalate, calcium, cysteine, urate, phosphate, and xanthine, among other substances. Modern medicine has developed excellent procedures and devices for treating kidney stones.
The American Urologic Association reports that the expense of diagnosing and treating kidney stones, both directly and indirectly, has been rising in recent years. Healthcare spending for kidney stone disease management has gone up, even if there have been improvements in therapeutic and surgical treatment methods. Medical treatment for kidney stones in the United States is projected to cost 1.24 billion dollars per year by 2031, according to the National Center for Biotechnology Information (NCBI). Patients have been able to keep their healthcare costs down because to technology advancements that have allowed for shorter hospital stays and less invasive surgical treatments.
Revenue in the kidney stone management market was negatively affected by the COVID-19 outbreak. There has been an effect on the implementation of kidney stone management methods from the increasing demand for COVID-19 treatment. People avoided various medical procedures in healthcare facilities due to the pandemic, which raised the incidence and death rates from coronavirus. All elective surgical treatments, whether performed in an outpatient or inpatient setting, were outlawed in numerous countries once they proclaimed a national emergency. These factors had an effect on the expansion of the worldwide market for kidney stones management.
Optimal therapy and better management of stones of any size have been made possible by technological developments and the introduction of novel products. In 2014, the GLIDEWAY ureteral access sheath was introduced by Terumo Corporation. It is utilized in minimally invasive urologic operations. The LithoVue single-use digital flexible ureteroscopes, introduced to the European market by Boston Scientific in 2016, offered superior visualization compared to the market leaders in 2016.
The kidney stone management devices market is anticipated to be influenced by ongoing research into the prevention and effective treatment of kidney stone illnesses. For example, a two-year clinical trial to find out how to avoid kidney stone recurrence was initiated in 2017 by Duke Clinical Research Institute (DCRI), a scientific data research center for the Urinary Stone Disease Research Network. The American Urological Association (AUA) also issued updated recommendations for the surgical removal of kidney stones in 2016. Most importantly, patients and doctors should work together to decide on a course of treatment and therapy for kidney stones. Renal stones, which are small, hard mineral deposits inside the kidneys, as well as ureteral stones, are addressed in these advice from experts.
Report Coverage
Global Kidney Stone Management Devices research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Kidney Stone Management Devices report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Kidney Stone Management Devices competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Kidney Stone Management Devices market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Allengers Medical Systems Ltd, Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, Coloplast A/S, Karl Storz GmbH, Richard Wolf GmbH, Dornier MedTech, EDAP TMS S.A, Medispec Ltd, DirexGroup, Elmed Medical Systems, Becton, Dickinson and Company, Siemens Healthineers. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Kidney Stone Management Devices Market from 2021 to 2031.
- Market Forecast for Kidney Stone Management Devices Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Kidney Stone Management Devices competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Kidney Stone Management Devices
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Kidney Stone Management Devices market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Kidney Stone Management Devices market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Allengers Medical Systems Ltd, Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, Coloplast A/S, Karl Storz GmbH, Richard Wolf GmbH, Dornier MedTech, EDAP TMS S.A, Medispec Ltd, DirexGroup, Elmed Medical Systems, Becton, Dickinson and Company, Siemens Healthineers.
Primary Target Market
- Market Players of Kidney Stone Management Devices
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Kidney Stone Management Devices market based on the below-mentioned segments:
Global Kidney Stone Management Devices Market, By Type
Calcium oxalate
Calcium phosphate
Uric acid
Struvite
Cysteine
Global Kidney Stone Management Devices market, By Diagnostics
Abdominal X-ray
Computed tomography
Ultrasound
Abdominal MRI
Intravenous pyelography
Others
Global Kidney Stone Management Devices Market, By Treatment
Extracorporeal shock wave lithotripsy (ESWL)
Ureteroscopy
Percutaneous nephrolithotomy (PCNL)
Others
Global Kidney Stone Management Devices market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive kidney stone management devices market market research and competitor analysis for your business to help you develop more profound insights into the kidney stone management devices market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the kidney stone management devices market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.